NASDAQ:TCDA
Delisted
Tricida Inc Stock News
$0.108
+0 (+0%)
At Close: Apr 21, 2023
New York, New York--(Newsfile Corp. - March 2, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Tr
New York, New York--(Newsfile Corp. - March 1, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Tricida, Inc. (NASDAQ: TCDA) alleging that
New York, New York--(Newsfile Corp. - March 1, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of
NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities clas
Tricida, Inc.'s (TCDA) CEO Gerrit Klaerner on Q4 2020 Results - Earnings Call Transcript
10:58am, Sunday, 28'th Feb 2021
Tricida, Inc.'s (TCDA) CEO Gerrit Klaerner on Q4 2020 Results - Earnings Call Transcript
New York, New York--(Newsfile Corp. - February 27, 2021) - WHY: New York, N.Y., February 27, 2021. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Tricida, I
Tricida Shareholder Alert
08:27am, Saturday, 27'th Feb 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Tricida To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Co
Here's Why Tricida Shares Plummeted Today
02:00pm, Friday, 26'th Feb 2021
The FDA denied the biotech's appeal, but there's still a path forward for its drug.
Why Is Tricida Trading Lower?
06:22am, Friday, 26'th Feb 2021
Tricida Inc (NASDAQ: TCDA) has received an Appeal Denied Letter (ADL) from the Office of New Drugs (OND) of the FDA in response to the company's Formal Dispute Resolution Request (FDRR) submitted
New York, New York--(Newsfile Corp. - February 25, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities o
SHAREHOLDER ALERT: Tricida, Inc. Sued for Violations of the Federal Securities Laws; Investors Should Contact Block & Leviton LLP
05:34pm, Thursday, 25'th Feb 2021
BOSTON, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Nationally-recognized securities law firm Block & Leviton LLP (www.blockleviton.com) announces that a lawsuit for violation of the federal securities laws has
Tricida Announces Fourth Quarter and Full Year 2020 Financial Results
04:10pm, Thursday, 25'th Feb 2021
SOUTH SAN FRANCISCO, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug cand
Tricida Provides Update on FDA Interactions
04:05pm, Thursday, 25'th Feb 2021
Tricida Has Received an Appeal Denied Letter from the Office of New Drugs of the FDA in Response to its Formal Dispute Resolution Request Tricida Has Received an Appeal Denied Letter from the Office o
NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stoc
NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class
